NeuroQuest Secures $250,000 in Funding from SC Launch Inc.
Deal News | May 15, 2025 | Trendlines Group Ltd/The
SC Launch Inc., a venture by the South Carolina Research Authority, has committed a $250,000 investment to NeuroQuest. Based in Charleston, NeuroQuest is pioneering the development of NeuroScreen®. This platform, supported by innovative technology, aims to advance the capabilities of neurological diagnostic tools. This investment by SC Launch Inc. is indicative of their strategy to support innovative health tech companies that have the potential to transform industries...
Sectors
- Healthcare Technology
- Venture Capital & Private Equity
Geography
- United States – NeuroQuest is based in Charleston, South Carolina, and SC Launch Inc. operates under the South Carolina Research Authority, establishing the geographical focus in the United States.
Industry
- Healthcare Technology – NeuroQuest, the target company, is involved in developing diagnostic tools for neurological conditions. This makes it part of the healthcare technology sector.
- Venture Capital & Private Equity – SC Launch Inc. is the investment arm of the South Carolina Research Authority, functioning within the venture capital and private equity sector by investing in early-stage companies.
Financials
- $250,000 – The investment made by SC Launch Inc. in NeuroQuest.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| NeuroQuest | Target Company | Company | NeuroQuest is developing NeuroScreen®, a new tool for neurological diagnostics. |
| SC Launch Inc. | Investor | Company | SC Launch Inc. is an investment initiative under the South Carolina Research Authority, aimed at supporting innovative companies. |